Patents by Inventor Damon I. PAPAC

Damon I. PAPAC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160367541
    Abstract: The invention relates to methods of treating diseases, particularly cancers, that respond favorably to the inhibition of Nicotinamide phosphoribosyltransferase (Nampt); it also relates to therapeutic methods that utilize Nampt inhibitors in combination with NAD biosynthesis precursors to intentionally kill cancer cells while limiting or minimizing toxicity to normal host cells; and it relates to methods of identifying cancers that will be most responsive to treatment with Nampt inhibitors, particularly when administered in combination with nicotinic acid.
    Type: Application
    Filed: November 12, 2014
    Publication date: December 22, 2016
    Applicant: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
    Inventors: Tracey C. Fleischer, Daniel M. Cimbora, Jeffrey S. Flick, Andrew D. Gassman, Vijay R. Baichwal, Damon I. Papac
  • Patent number: 8912184
    Abstract: The invention relates to methods of treating diseases, particularly cancers, that respond favorably to the inhibition of Nicotinamide phosphoribosyltransferase (Nampt); it also relates to therapeutic methods that utilize Nampt inhibitors in combination with NAD biosynthesis precursors to intentionally kill cancer cells while limiting or minimizing toxicity to normal host cells; and it relates to methods of identifying cancers that will be most responsive to treatment with Nampt inhibitors, particularly when administered in combination with nicotinic acid.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: December 16, 2014
    Assignee: Alzheimer's Institute of America, Inc.
    Inventors: Tracey C. Fleischer, Daniel M. Cimbora, Jeffrey S. Flick, Andrew D. Gassman, Vijay R. Baichwal, Damon I. Papac
  • Publication number: 20120277257
    Abstract: Disclosed herein are methods of treating diseases and disorders responsive to inhibition of Hsp90, pharmaceutical compositions, pharmaceutical dosage forms and medicaments useful for the treatment of diseases responsive to inhibition of Hsp90, and methods of making the pharmaceutical compositions, pharmaceutical dosage forms and medicaments.
    Type: Application
    Filed: May 14, 2012
    Publication date: November 1, 2012
    Applicant: MYREXIS, INC.
    Inventors: Margaret YU, Daniel A. WETTSTEIN, Vijay R. BAICHWAL, Damon I. PAPAC, Gaylen M. ZENTNER, Mark S. WILLIAMS